Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/01/2012US20120053231 Prevention and treatment of nosema disease in bees
03/01/2012US20120053230 TREATMENT OF NEUROLOGICAL DISORDERS BY dsRNA ADMINISTRATION
03/01/2012US20120053229 Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053227 miR-33 INHIBITORS AND USES THEREOF
03/01/2012US20120053226 Design of oligonucleotide analogs as therapeutic agents
03/01/2012US20120053225 Akt tyrosine 176 phosphorylation cancer biomarker
03/01/2012US20120053224 Compositions and methods for micro-rna expression profiling of cancer stem cells
03/01/2012US20120053223 Compositions and methods for treating retrovirus infections
03/01/2012US20120053222 Novel Metabolic Disease Therapy
03/01/2012US20120053220 Novel lipoxygenase inhibitors as neuroprotective agents
03/01/2012US20120053219 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/01/2012US20120053218 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
03/01/2012US20120053214 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
03/01/2012US20120053213 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside hiv reverse transcriptase, preparation methods and uses thereof
03/01/2012US20120053212 Methods of treating humans undergoing injection of a contrast agent
03/01/2012US20120053211 Treatment of pancreatic cancer
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053209 Anticancer compounds, preparation thereof, and therapeutic use thereof
03/01/2012US20120053208 Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same
03/01/2012US20120053207 Antipsychotic treatment based on drd2 or ankk1 snp genotype
03/01/2012US20120053206 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053205 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053204 Substituted quinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053203 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053202 POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF
03/01/2012US20120053201 Substituted hydroxamic acids and uses thereof
03/01/2012US20120053200 Bace 2 inhibitors
03/01/2012US20120053199 Noscapine and analogs and methods related thereto
03/01/2012US20120053198 Water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins
03/01/2012US20120053197 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
03/01/2012US20120053196 Combination Treatment of Breast Cancer
03/01/2012US20120053195 Hydrobromide salts of a pyrazolylaminoquinazoline
03/01/2012US20120053194 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/01/2012US20120053193 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/01/2012US20120053192 Heterocyclic Substituted Acardite Derivate and Application Thereof
03/01/2012US20120053191 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
03/01/2012US20120053190 Organic compounds
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053188 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
03/01/2012US20120053187 Tri-cyclic pyrazolopyridine kinase inhibitors
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053185 Method to treat melanoma in braf inhibitor-resistant subjects
03/01/2012US20120053184 Salts of 3-(1h-ind0l-3-yl)-4-[2-(4-methyl-piperazin-i-yl)-quinazolin-4-yl]-pyrrole-2, 5-di one
03/01/2012US20120053183 Piperazinylpyrimidine analogues as protein kinase inhibitors
03/01/2012US20120053182 Methods of alleviating or treating signs and/or symptoms associated with moderate to severe parkinson's disease
03/01/2012US20120053181 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/01/2012US20120053180 Cyclohexane analogues as gpr119 agonists
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053178 3-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
03/01/2012US20120053177 Compounds and methods for kinase modulation, and indications therefor
03/01/2012US20120053176 Adenosine a3 receptor modulating compounds and methods of use thereof
03/01/2012US20120053175 Mlk inhibitors and methods of use
03/01/2012US20120053174 Quinazoline compounds and methods of use thereof
03/01/2012US20120053173 Heterocyclic compound
03/01/2012US20120053172 Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
03/01/2012US20120053171 Nitrogen-Containing Fused Heterocyclic Compounds and Their use as Beta Amyloid Production Inhibitors
03/01/2012US20120053170 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
03/01/2012US20120053169 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
03/01/2012US20120053168 Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligands
03/01/2012US20120053167 Triazine Derivatives as Kinase Inhibitors
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053165 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053163 Steroids as Agonists for FXR
03/01/2012US20120053162 Certain chemical entities, compositions, and methods
03/01/2012US20120053161 Topical solution formulations containing a corticosteroid and a cyclodextrin
03/01/2012US20120053160 Dosage Form for Hormonal Contraception
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053158 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
03/01/2012US20120053157 Methods for the treatment or prophylaxis of thrombosis or embolism
03/01/2012US20120053156 Compositions and methods for loop diuretics with consistent bioavailability
03/01/2012US20120053155 System and method for reverting antibiotic tolerance of bacterial persister cells
03/01/2012US20120053154 Composition and method for inhibiting biogenic sulfide generation
03/01/2012US20120053153 Topical gel formulation comprising organophosphate insecticide and preparation thereof
03/01/2012US20120053152 (R)-(-)-1,2-propanediol compositions and methods
03/01/2012US20120053150 N-pyrazolyl carboxamides as crac channel inihibitors
03/01/2012US20120053149 Thiazole derivatives and their use as p2y12 receptor antagonists
03/01/2012US20120053148 Inhibitors of hepatitis c virus
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053145 Aripiprazole complex formulation and method
03/01/2012US20120053144 Cobalamin Taxane Bioconjugates For Treating Eye Disease
03/01/2012US20120053143 Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat
03/01/2012US20120053142 Compositions and methods for minimizing and/or reducing the appearance of defects around eyes
03/01/2012US20120053141 Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
03/01/2012US20120053140 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
03/01/2012US20120053139 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
03/01/2012US20120053138 Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
03/01/2012US20120053137 Method for Treating Addiction Using Quercetin-Containing Compositions
03/01/2012US20120053136 Diagnosis and treatment of drug-resistant ewing`s sarcoma
03/01/2012US20120053135 Drug composition for treating chronic liver disease and its application
03/01/2012US20120053134 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
03/01/2012US20120053132 Compositions and methods for inhibiting cytochrome p450
03/01/2012US20120053131 Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
03/01/2012US20120053130 Composition for enhancing absorption of a drug and method
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053117 Pharmaceutical composition, drug screening method and method for treating malaria
03/01/2012US20120053112 Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion
03/01/2012US20120053052 3-Arylquinazolin-4-one compounds for combating invertebrate pests
03/01/2012US20120052573 One-pot synthesis of linear-like polyethylenimine for intracellular imaging and nucleic acid delivery
1 ... 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 ... 7860